Oncologists reveal reasons for high cost of cancer drugs in U.S.

Increasingly high prices for cancer drugs are affecting patient care in the U.S. and the American health care system overall, say researchers. „Americans with cancer pay 50 percent to 100 percent more for the same patented drug than patients in other countries,“ says one of the authors. „As oncologists we have a moral obligation to advocate for affordable cancer drugs for our patients.“ (Mehr in: Cancer News — ScienceDaily)